Ignite Creation Date:
2024-05-06 @ 12:23 PM
Last Modification Date:
2024-10-26 @ 12:58 PM
Study NCT ID:
NCT03747744
Status:
UNKNOWN
Last Update Posted:
2020-12-29
First Post:
2018-11-16
Brief Title:
Intratumoral Injection of Autologous CD1c BDCA-1 Myeloid Dendritic Cells Plus Talimogene Laherparepvec T-VEC
Sponsor:
Organization:
Universitair Ziekenhuis Brussel
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
18
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: